Immunetrics’ disease models span across acute inflammation, chronic, autoimmune conditions, and immuno-oncology.
These models can be customized to meet specific needs and are constantly evolving to support new research outcomes.
|
Disease Models |
Key Outputs |
Supported Therapeutics |
|
Rheumatoid Arthritis
|
Swollen/tender joint counts
ACR20/50/70 DAS28(3)-CRP/ESR Low disease activity Remission Serum cytokines and biomarkers Serum cell counts |
MTX
5-ASA Corticosteroids JAK inhibitors Anti-TNFs Anti-IL6s Anti-IL17s Anti-T and B cell therapies Anti-Survival therapies Anti-Migration therapies |
|
Psoriatic Arthritis / Psoriasis |
Swollen/tender joint counts
ACR20/50/70 DAS28(3)-CRP/ESR PASI 50/75/90/100 Serum cytokines and biomarkers Serum cell counts |
MTX
5-ASA Corticosteroids JAK inhibitors Anti-TNFs Anti-IL6s Anti-IL17s Anti-IL12/23 Anti-T and B cell therapies Anti-Survival therapies Anti-Migration therapies |
|
Ulcerative Colitis |
Mayo score
Response/Remission Mucosal healing Serum cytokines and biomarkers |
MTX
5-ASA Corticosteroids Anti-TNFs JAK inhibitors S1P receptor antagonist |
| Immuno-oncology
Melanoma Lymphoma Leukemia |
RECIST criteria
Lesion size changes Serum cytokines and biomarkers
|
Proprietary |
|
Sepsis Multi-Organ Dysfunction
|
Mean arterial pressure (MAP)
Central venous pressure (CVP) Blood oxygen saturation (O2sat) Breathing frequency Tidal volume Blood gases (PaO2, PaCO2) Creatinine Urinary output (UOP) Coagulation proteins |
Fluid therapy
Vasopressors Ventilators Diuretics Dialysis Antibiotics |
|
Trauma |
Cytokines
Immune cells Coagulation proteins Blood loss Mean arterial pressure (MAP) Blood oxygen saturation (O2sat) |
Fluid therapies
Blood products Ventilators |